Inventprise Cuts 40% of Workforce as Vaccine Startup Faces Funding Headwinds
Vaccine developer Inventprise is cutting 76 workers across its Washington facilities, representing nearly 40% of its workforce. The layoffs come as the company advances its pneumococcal vaccine candidate through clinical trials.